Novel Psychoactive Substances

Dr. Ornella Corazza is a Reader in Substance Addictions and Behaviours at University of Hertfordshire and leading expert in the field of Novel Psychoactive Substances (NPS). She has published numerous papers in the field and her work has been recognized and prized internationally, including with the 2013 European Health Award. She has previously held Fellowships at the University of Padua (Italy), University of Bochum (Germany), University of London (SOAS; King’s College) and at the Centre of Excellence on Death and Life Studies at the University of Tokyo (Japan). She is also a Visiting Professor at Sapienza University of Rome. As a consequence of working internationally in different academic environments, she has developed a unique specialism in the combined fields of health, culture and legislation. In total, Dr Corazza is author of over 200 journal articles, book chapters and conference papers. They cover the main classes of NPS as well new methods for the rapid identification of novel drug trends, prevention and policy recommendations.Dr Andres Roman-Urrestarazu combined expertise in psychiatry, mental health and health economics allowed him to make original contributions in the fields of substance abuse where he has developed a growing body of research in the field of NPS Policy. He is Assistant Professor at Maastricht University Department of International Health and concurrently holds the Gilling’s Fellowship in Global Public Health at the Institute of Public Health (IPH), University of Cambridge and the Institut Louis Pasteur (ILP) Paris. He currently co-supervises PhD students at the IPH in Cambridge and Maastricht University Department of International Health where he leads a project that studies the association between austerity, macroeconomic indicators and substance misuse. Concurrently with this policy agenda, his clinical work and research is based in the Autism Research Centre, Department of Psychiatry, University of Cambridge where he works on neurodevelopment disorders and more specifically ASD, disability, inequality and social policy. He has previously held appointments as Research Officer in Health Economics and Health Policy at LSE Health, London School of Economics and Political Science working extensively in the Middle East on behavioural risk factors for metabolic disease in collaboration with WHO, GIZ/GTZ and ILO among others, while also developing a teaching career in Trinity Hall, Cambridge where he was Director of Studies in Psychology and Behavioral Science. He has also worked in different government roles around the world having worked as Technical Lead at the Centre for Health Technology Evaluation (CHTE) in the National Institute for Health and Care Excellence and also as Medical Advisory Staff at the Ministry of Health Chile - MINSAL. He has published several papers in relation to NPS while also submitting evidence to the House of Commons for the 2016 UK PSA. In that occasion, he assisted the discussion around NPS with a comparative policy analysis, while also managing the engagement with the press for the dissemination of this evidence. His latest book, in co-authorship with Dr Ornella Corazza, discusses different global policy options for NPS having collaborated for this work with different international organisations such as the European Commission, UNODC, DEA, WADA, LSE Ideas, and various leading academics in the field of drug policy. Dr Andres Roman-Urrestarazu specialises in Psychiatry (MD  and BM in Medicine, University of Santiago de Chile; PhD Psychiatry, University of Cambridge), Health Economics and Policy (MSc London School of Economics).

1.The Global Emergence of NPS: An Analysis of a New Drug Trend.- 2.Legislating NPS in the European Union.- 3.Regulation as Global Drug Governance - How New is the NPS Phenomenon?.- 4.Anti-Doping Challenges with Novel Psychoactive Substances in Sport.- 5.Exploring Novel Policy Responses to NPS and 'legal highs' in New Zealand, Poland, Republic of Ireland and the United Kingdom.- 6.Regulating NPS in the Middle East: A Critical Juncture.- 7.Finding Novel Policy Response to the Challenge of NPS in Kazakhstan: Reconsidering Existing Policy and the Work of Health Professionals.- 8.NPS Policy Pitfalls: The Implementation and Management Challenges Within the Prison, Police and Health Services in the United Kingdom.- 9.NPS: An Opportunity to Move From Blanket Prohibition to a More Functionalist Approach?.- 10.The Challenges in Interpreting National-Level Strategic Indicators: A Drug Enforcement Administration Analyst's Perspective.- 11.Harmonizing NPS Legislation Across the European Union: An Utopia?.- 12.New psychoactive substances: The Regulatory Experience and Assessment of Options.